SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-20-009122
Filing Date
2020-02-13
Accepted
2020-02-13 13:54:04
Documents
1
Period of Report
2019-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 2452
  Complete submission text file 0001209191-20-009122.txt   3795
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Issuer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O UROGEN PHARMA LTD. 9 HA TA ASIYA STREET RA ANANA L3 4365007
Business Address
Schoenberg Mark (Reporting) CIK: 0001763581 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-38079 | Film No.: 20608966